Authors' objectives: To evaluate the efficacy, safety, cost-effectiveness and organisational issues related to the mobile C-arm fluoroscopic system for cardiothoracic surgery.

Authors' results and conclusions: There were limited evidence retrieved on efficacy. The evidence showed that this system had a potential to float and position safely a pulmonary artery catheter in a shorter time. Moreover, the mobile C-arm may be used to confirm the location of microcoil while performing a thoracoscopic surgery without the need to transfer the patient to any other room. The malposition and cardiac arrhythmias was lesser when this system was used. Furthermore, there were various mobile C-arm fluoroscopy registered with the Medical Device Authority. The mobile C-arm fluoroscopy also had received 510(k) from US FDA. The system requires an adequate operating room size, along with the sufficient existing infrastructure, and needs to be operated optimally. The price range of mobile C-arm fluoroscopy was from USD15,000 to USD130,000 (RM62,767 to RM543,985) regardless of the product brands and manufacturers.

Authors' recommendations: A mobile C-arm fluoroscopy may be used in Ministry of Health facilities for cardiothoracic surgery. However, it depends on space, existing infrastructure of the room and operating time, which must be taken into consideration to ensure the optimum use of the system.

Authors' methods: Electronic databases were searched through the Ovid interface; Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) 1946 to 27 July 2021, Ovid MEDLINE(R) and Epub Ahead of Print, In-Process, In-Data-Review & Other Non-Indexed Citations and Daily 1946 to July 27, 2021, Ovid MEDLINE(R) and In-Process, In-Data-Review & Other Non-Indexed Citations 1946 to July 27, 2021, Ovid MEDLINE(R) and Epub Ahead of Print, In-Process, In-Data-Review & Other Non-Indexed Citations and Daily 2017 to July 27, 2021, Ovid MEDLINE(R) 1946 to July Week 3 2021, Ovid MEDLINE(R) 1996 to July Week 3 2021, Ovid MEDLINE(R) Epub Ahead of Print July 27, 2021, Ovid MEDLINE(R) Daily Update July 27, 2021 and Ovid MEDLINE(R) 2017 to July Week 3 2021. Searches were also run in PubMed, INAHTA, Cochrane Library and US Food and Drug Administration. Google was used to search for additional web-based materials and information. Additional articles were identified from reviewing the references of retrieved articles. Last search was conducted on 2 August 2021.

Authors' identified further research: -

Project Status: Completed

Year Published: 2021

URL for published report: https://www.moh.gov.my/index.php/database_stores/store_view_page/30/380

Requestor: Ministry of Health

English language abstract: An English language summary is available

Publication Type: Mini HTA

Country: Malaysia

Organisation Name: Malaysian Health Technology Assessment

Contact Address: Malaysian Health Technology Assessment Section, Ministry of Health Malaysia, Federal Government Administrative Centre, Level 4, Block E1, Parcel E, 62590 Putrajaya Malaysia Tel: +603 8883 1229

Contact Name: htamalaysia@moh.gov.my

Contact Email: htamalaysia@moh.gov.my

Copyright: Malaysian Health Technology Assessment Section (MaHTAS)